Plogosertib

N/A

Report date: 2024/12/13 13:26:49
NME

Base Information

Drug NamePlogosertib
Drug Alias NameCYC-140CY-140
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolo like kinase 1 inhibitors
TargetsPolo like kinase 1
Therapy Area/IndicationsSolid tumoursMyelodysplastic SyndromesLymphoma +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSpainSouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCyclacel Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesTethra Biosciences IncCyclacel Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursLymphoma
Inactive IndicationsMyelodysplastic SyndromesLeukemia, Myeloid, AcuteLeukemia, Myeloid +[5] 

Other Information

ATC CodeN/A
Related LinksN/A